skip to Main Content
Get your free newsletter: Actionable insight each morning for self-directed investors. 

London’s AIM index may have only seen modest losses on Wednesday but that makes for a seventh consecutive day of declines. At the bell the market was down just over three points at 1274.89

  • Sabien Technologies +93%
  • Pipehawk +16%
  • Character Group -15%
  • Renalytix -12%
  • Image Scan -10%

Sabien Technologies [LND:SNT] made a sound impression, adding some 93% by the bell. The company announced a sales agency agreement this morning, giving it exclusive rights to sell the technology of a Korean company, City Oil Field, which provides innovative ways to reduce waste exports and also sending rubbish to landfill. Volumes were recorded at more than 14 million shares trading hands, almost as many as are in circulation!

Pipehawk [LND:PIP] came in second place, but with gains limited to just 16% it was a fair way off the pace. There’s no firm news out, but interest in the stock has been elevated. The 7% spread also needs to be taken into account.

Subscribe for more stories like this, 8am weekdays - for free!

Character Group [LND:CCT] was the day’s worst performer, off some 15% in the wake of a trading update. There’s nothing of great consequence in this, other than an acknowledgement that global supply chain issues are likely to weigh on full year profitability, although knocking no more than 10% off expectations.

Renalytix [LND:RENX] is on the radar again, shedding 12%. A regulatory update after the close last night is resulting in some delays for the business, although the company doesn’t believe this will result in a material impact. With the shares having bounced off lows shortly after the open, the downside here may be exhausted already.

A notable mention for Image Scan [LON:IGE] who have been on our radar for the last few days. Shares slipped 10% today, giving back yesterday’s gains but still holding onto the upside accrued off the back of that trading update on Monday.


Please note this article does not constitute investment advice. Investors are encouraged to do their own research beforehand or consult a professional advisor.

Tony Cross

Tony Cross

Tony Cross is a market commentator with over 15 years of experience, producing compelling, insightful copy for journalists and investors alike. Focusing on macroeconomics, UK blue chip equities and inter market analysis, Cross's commentary is well regarded for its clarity and ability to cut through the waffle. He has been quoted in publications as diverse as The Financial Times, The Times, The Guardian and The Sun. He has also been a regular guest on both Share Radio and TipTV.

Stocks in Focus

Here are some of the smaller companies we are following most closely. They all represent significant growth stories in our view. Our in-depth reports go into more detail on why we like them.


Subscribe for more stories like this, 8am weekdays - for free!

Get your free daily newsletter: 

Thanks to our Partners

Our partners are established, regulated businesses and we are grateful for their support.

FP Markets
Back To Top